Literature DB >> 9683089

Private sector health reform in South Africa.

A M Van Den Heever.   

Abstract

This paper discusses some of the trends, debates and policy proposals in relation to the financing of the private health sector in South Africa. The public and private sectors in South Africa are of equivalent size in terms of overall expenditure, but cover substantially different population sizes. Within this context the government has reached the unavoidable conclusion that the private sector has to play some role in ensuring that equity, access and efficiency objectives are achieved for the health system as a whole. However, the private sector is some way off from taking on this responsibility. Substantial increases in per capita costs over the past 15 years, coupled with a degree of deregulation by the former government, have resulted in increasing instability and volatility. The development of a very competitive medical scheme (health insurance) market reinforced by intermediaries with commercial interests has accelerated trends toward excluding high health risks from cover. The approach taken by the government has been to define a new environment which leaves the market open for extensive competition, but removes from schemes the ability to compete by discriminating against high health risks. The only alternatives left to the private market, policy makers hope, will be to go out of business, or to survive through productivity improvements.

Mesh:

Year:  1998        PMID: 9683089     DOI: 10.1002/(sici)1099-1050(199806)7:4<281::aid-hec355>3.0.co;2-z

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  2 in total

1.  Aggregation and the measurement of health care costs.

Authors:  Thomas E Getzen
Journal:  Health Serv Res       Date:  2006-10       Impact factor: 3.402

Review 2.  Comparative performance of private and public healthcare systems in low- and middle-income countries: a systematic review.

Authors:  Sanjay Basu; Jason Andrews; Sandeep Kishore; Rajesh Panjabi; David Stuckler
Journal:  PLoS Med       Date:  2012-06-19       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.